In modeled animals, the anti-HMGB1 monoclonal antibody (mAb) has also been proven to be useful for the treatment of a variety of CNS illnesses, notably hemorrhage, brain trauma, Parkinson's disease and Alzheimer's disease [33]. The gene discussed is HMGB1; the disease is Parkinson disease.